Patrizia Cavazzoni (Duke Margolis via YouTube)
April 5, 2022 05:29 AM EDTUpdated April 13, 09:48 AM
FDA+

CDER chief calls for ad­di­tion­al bud­get funds as staff de­par­tures spiked last sum­mer

Zachary Brennan

Senior Editor

When Pa­trizia Cavaz­zoni of­fi­cial­ly took the reins of FDA’s Cen­ter for Drug Eval­u­a­tion and Re­search last April, much of the at­ten­tion on her move to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times